Could BioNTech’s New mRNA Technology for COVID-19 Treat Cancer?


Could BioNTech’s New mRNA Technology for COVID-19 Treat Cancer?

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Healthy Living | Cancer Disease Prevention, Control, and Treatment | COVID-19 Vaccine for Cancer Treatment

Public Health care Education

Photo credit: shareing-careing-org

Could BioNTech’s new mRNA Technology treat cancer as two doctors are exploring a new technology involving messenger RNA (mRNA), to treat cancer?

Two doctors are exploring a new technology involving messenger RNA (mRNA), to treat cancer.

Professors Ugur Sahin and Ozlem Tureci who co-founded the German company BioNTech in 2008 are hopeful that the new technology could lead to new treatments for melanoma, bowel cancer, and other tumour types ever since BioNTech’s mRNA cancer trials which started long before the pandemic have shown some early encouraging signals. So, could BioNTech’s New mRNA Technology for COVID-19 treat cancer?

The approved drug, Lumakras, is proving effective in cancer treatment

BioNTech has several trials in progress, including one where patients are given a personalized vaccine, to prompt their immune system to attack their disease.

The mRNA technology being used works by sending an instruction or blueprint to cells to produce an antigen or protein which teaches the immune system to recognize target affected cells for termination.

Harnessing the potential of mRNA to produce vaccines was unverified until COVID-19. Still, the success of mRNA vaccines in the pandemic has encouraged many scientists to work with the technology to find a cure for cancer.

Since many promising cancer trials fail, caution is needed. It may be several years before we know if BioNTech’s treatments for bowel cancer, melanoma and other tumour types really do take on cancer.

United States approves COVID-19 vaccines for children under 6 months of age.

According to the BBC report, BioNTech’s chief medical officer, Professor Ozlem Tureci, said that every step, every patient they treated in their cancer trials helped them to find out more about what they were against and how to address that,” Prof Tureci, BioNTech’s chief medical officer.

Colin Powell, first Black US secretary of state, dies of Covid-19 complications amid cancer battle

Prof Tureci said: “mRNA acts as a blueprint and allows you to tell the body to produce the drug or the vaccine… and when you use mRNA as a vaccine, the mRNA is a blueprint for the ‘wanted poster’ of the enemy – in this case, cancer antigens which distinguish cancer cells from normal cells.”

New COVID-19 wave emerging in Europe – WHO

This blog content on ‘Could BioNTech’s New mRNA Technology for COVID-19 Treat Cancer as two doctors are exploring a new technology involving messenger RNA (mRNA), to treat cancer?’ is categorized under Public Health care Education.

Our Public Health care Education System is about creating and delivering impacting, and empowering problem-solving information towards enhancing prevention and control of Cancer and COVID-19 and its variants spread to our amiable readers for better healthy and sustainable livelihood – Eduonwheels.

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments

Read More Posts

Enable Notifications OK No thanks